close

TransMedics: Q3 Earnings Snapshot

By Stats Perform Dba Automated Insights 1 min read

ANDOVER, Mass. (AP) — ANDOVER, Mass. (AP) — TransMedics Group Inc. (TMDX) on Monday reported a loss of $25.4 million in its third quarter.

The Andover, Massachusetts-based company said it had a loss of 78 cents per share. Losses, adjusted for non-recurring costs, came to 12 cents per share.

The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 18 cents per share.

The medical technology company posted revenue of $66.4 million in the period, which also topped Street forecasts. Four analysts surveyed by Zacks expected $48.1 million.

TransMedics expects full-year revenue in the range of $222 million to $230 million.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TMDX at https://www.zacks.com/ap/TMDX

CUSTOMER LOGIN

If you have an account and are registered for online access, sign in with your email address and password below.

NEW CUSTOMERS/UNREGISTERED ACCOUNTS

Never been a subscriber and want to subscribe, click the Subscribe button below.

Starting at $4.79/week.

Subscribe Today